American Airlines Boosts Travelers’ Peace of Mind with VUMC Expertise

Newswise — Taking new actions that focus on the well-being and safety of customers and team members, American Airlines today announced that it has created a new Travel Health Advisory Panel that includes Vanderbilt University Medical Center (VUMC) infectious disease experts to advise on health and cleaning matters as travelers return over the summer.

The panel will include VUMC experts David Aronoff, MD, Director of the Division of Infectious Diseases, and Thomas Talbot, MD, MPH, Chief Hospital Epidemiologist, national leaders in the field of infectious disease prevention. These experts will provide American with the latest information from public health authorities and scientific research as well as advice and guidance on disease prevention, cleaning procedures and other public health matters. The panel, which will include other safety and operations experts, will help American Airlines continue to improve and innovate its cleaning procedures and ensure customers always feel safe in the skies.

“We’re pleased to have access to new guidance on infectious diseases from the experts at Vanderbilt University Medical Center,” said Alison Taylor, American’s Chief Customer Officer. “Drs. Aronoff and Talbot will be an important part of our decision-making process on issues including cleaning, health screening, and infection prevention and control.”

“We are proud to be advising a worldwide aviation leader like American Airlines as it works diligently to bring a new level of health and safety to the skies,” said Jeff Balser, MD, PhD, President and CEO of VUMC. “As part of the Travel Health Advisory Panel, our infectious disease experts are working closely with leaders at American to help them identify and apply COVID-19 safety and infection prevention best practices for their team members and passengers around the world.”

The new panel complements American’s existing work with medical director Dr. Stan Miller, and its ongoing consulting with the Centers for Disease Control and Prevention and other outside experts.

In May, American began requiring all customers and team members on board to wear a face covering unless there is a medical reason why they cannot. And earlier this month American said it would limit flight privileges for customers who refuse to wear a face covering without a medical reason. Face masks are also required for customers throughout their journey at most of American’s hub airports, and American continues to encourage airports to make this the standard. Wearing a face covering continues to be one of the most important ways travelers can protect themselves and others while flying.

In addition, beginning June 30, American will begin asking customers during the check-in process to certify that they have been free of COVID-19 symptoms for the past 14 days. American worked with VUMC to develop the COVID-19 symptom checklist for each customer using self-service machines in airports or during online check-in at home. American has also been actively engaged with recent efforts by the industry trade group Airlines for America to put customer well-being first.

“Our customers trust us to make every aspect of their journey safe. We won’t let them down,” Taylor said. “We will continue to refine and update our practices based on the latest information from health authorities and our own Travel Health Advisory Panel.”

 

 




Filters close

Showing results

110 of 2816
access_time Embargo lifts in 2 days
Embargo will expire: 6-Aug-2020 11:00 AM EDT Released to reporters: 5-Aug-2020 4:25 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 6-Aug-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise:Video Embedded uab-department-of-pathology-develops-strategy-to-support-guidesafe-entry-testing-process-more-than-200-000-samples
VIDEO
Released: 5-Aug-2020 4:10 PM EDT
UAB Department of Pathology develops strategy to support GuideSafe™ Entry Testing, process more than 200,000 samples
University of Alabama at Birmingham

This strategy will allow for ramping up testing capacity tenfold for the next 20-plus days leading up to the start of school.

Newswise: 239458_web.jpg
Released: 5-Aug-2020 2:50 PM EDT
New findings on enzymes with important role in SARS-CoV-2 infection
Uppsala University

Researchers at Uppsala University have described the presence, throughout the human body, of the enzyme ACE2.

Newswise: Button Project Lets Children See the Faces Behind the Masks
Released: 5-Aug-2020 2:50 PM EDT
Button Project Lets Children See the Faces Behind the Masks
Vanderbilt University Medical Center

When COVID-19 cases began rising in Nashville, masking became a regular part of life across Vanderbilt University Medical Center and Children’s Hospital as one of several public health safety measures to protect employees and patients from potential COVID-19 exposure. Children’s Hospital decided to get creative to ensure that the 1,700 children and families who visit the hospital and clinics each day can see that the same friendly faces they’ve always known still exist behind the masks.

Newswise: 239490_web.jpg
Released: 5-Aug-2020 1:45 PM EDT
Massey scientist suggests COVID-19 should be treated as an acute inflammatory disease
Virginia Commonwealth University (VCU)

The COVID-19 pandemic has had detrimental effects on global infrastructure sectors, including economic, political, health care, education and research systems, and there is still no definitive treatment strategy for the disease.

Newswise: Helping protect medical professionals
Released: 5-Aug-2020 1:05 PM EDT
Helping protect medical professionals
Sandia National Laboratories

A media comprised of a sandwich of materials, tested by Sandia National Laboratories, is being manufactured into N95-like respirators that could be used in local medical facilities. The project originated from the urgent need for personal protective equipment when the COVID-19 outbreak began.

Released: 5-Aug-2020 12:50 PM EDT
UCI scientists get ‘initial hit’ in developing drug to treat COVID-19
University of California, Irvine

Irvine, Calif., Aug. 5, 2020 – When the coronavirus pandemic hit, almost everyone at the University of California, Irvine – and colleges across the nation – had to abandon campus. But James Nowick, professor of chemistry, was not a part of that exodus. That’s because his lab, which designs and constructs chemical molecules, had the right equipment to help in the global push to find treatments for COVID-19.


Showing results

110 of 2816

close
1.31446